Sanofi SNY
NASDAQ SNY
$41.60 -0.36 (-0.86%)
At close: Oct 23, 2026 · 4:00 PM EDT

Sanofi (SNY) Gains from Sales and Divestitures (2009 - 2014)

Updated

Sanofi's Gains from Sales and Divestitures was -$397.69 million in the year ended Dec 31, 2025, compared with -$396.14 million a year earlier.

Analysis

Sanofi (SNY) Gains from Sales and Divestitures (2009 - 2014) Analysis & Trends

From the year ended Dec 31, 2015 onward, Sanofi has reported Gains from Sales and Divestitures for 11 years.

  • The figure for the year ended Dec 31, 2025 marks the lowest annual Gains from Sales and Divestitures since the year ended Dec 31, 2022.
  • Per Business Quant data, Gains from Sales and Divestitures in earlier years was -$396.14 million in the year ended Dec 31, 2024, -$393.75 million in the year ended Dec 31, 2023, -$621.83 million in the year ended Dec 31, 2022 and -$355.02 million in the year ended Dec 31, 2021.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Eli Lilly 1,137.66 Bn 1,106.24 Bn 19.71 Bn
2 Johnson & Johnson 636.13 Bn 556.00 Bn 17.30 Bn
3 AbbVie 505.28 Bn 478.39 Bn 12.70 Bn
4 Merck 358.10 Bn 312.48 Bn 12.21 Bn
5 Novartis Ag 292.59 Bn 256.58 Bn 11.24 Bn
6 Astrazeneca 265.81 Bn 239.50 Bn 12.86 Bn
7 Amgen 237.53 Bn 192.93 Bn 7.24 Bn
8 Gilead Sciences 194.67 Bn 168.86 Bn 6.22 Bn
9 Pfizer 171.17 Bn 117.82 Bn 10.94 Bn
10 Sanofi 50.74 Bn 17.26 Bn 10.79 Bn
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2014 -256.22 Mn
Dec 31, 2013 355.24 Mn
Dec 31, 2012 111.53 Mn
Dec 31, 2011 -70.08 Mn
Dec 31, 2010 -150.73 Mn
Dec 31, 2009 -36.92 Mn
API Access

Sanofi Gains from Sales and Divestitures API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=gains-from-sales-and-divestitures&ticker=SNY&period=max&api_key=YOUR_API_KEY